Sean M. Murphy

Associate Professor of Research

Weill Cornell Medical College

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sean M. Murphy is an Associate Professor of Research at Weill Cornell Medical College in the United States. His research focuses on innovative treatment approaches for substance use disorders, including telemedicine and pharmacotherapy. He has authored several recent articles examining health interventions for marginalized communities, particularly transgender women and individuals with opioid use disorder.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (12)

Christina E. Freibott

Columbia University Irving Medical Center

UNITED STATES

View details

Veer Vekaria

Weill Cornell Medicine

UNITED STATES

View details

Avik Chatterjee

UNITED STATES

View details

Brandon D. L. Marshall

UNITED STATES

View details

Kathryn McCollister

Professor

University of Miami

UNITED STATES

View details

Sabrina A. Assoumou

Boston University School of Medicine

UNITED STATES

View details

Jeffrey Bratberg

Clinical Professor

University of Rhode Island

UNITED STATES

View details

Noa Krawczyk

NYU School of Medicine

UNITED STATES

View details

Arthur Robin Williams

Columbia University

UNITED STATES

View details

Keith Goldfeld

Associate Professor

NYU School of Medicine

UNITED STATES

View details

Czarina Behrends

Assistant Professor

Weill Cornell Medical College

UNITED STATES

View details

Jake Morgan

Assistant Professor

Boston University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sean M. Murphy

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial

The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States

The 2023 Addiction Health Services Research Conference: Back in Person and Taking a Bite of the Big Apple

Use of in-network insurance benefits is critical for improving retention in telehealth-based buprenorphine treatment

Protocol for a randomized controlled trial with a stepped care approach, utilizing PrEP navigation with and without contingency management, for transgender women and sexual minority men with a substance use disorder: Assistance Services Knowledge-PrEP (A.S.K.-PrEP)

Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID‐19 pandemic: An interrupted time‐series analysis in Massachusetts, USA

Telemedicine-delivered treatment for substance use disorder: A scoping review

Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration

Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17

Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost‐effectiveness analysis

Community‐based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island

Cost‐effectiveness implications of increasing the efficiency of the extended‐release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis

Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression

Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorder

Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials

Collaborators (12)

Christina E. Freibott

Veer Vekaria

Avik Chatterjee

Brandon D. L. Marshall

Kathryn McCollister

Sabrina A. Assoumou

Jeffrey Bratberg

Noa Krawczyk

Arthur Robin Williams

Keith Goldfeld

Czarina Behrends

Jake Morgan

Make your next move.